Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home
Share
Compartir

TB Guidelines

Listed by Date

On this page —

Title Format Date Published
Provisional CDC Guidelines for the Use and Safety Monitoring of Bedaquiline Fumarate (Sirturo) for the Treatment of Multidrug-Resistant Tuberculosis
MMWR 2013; 62 (No. 9)
PDF
(411 KB)
10/2013
Availability of an Assay for Detecting Mycobacterium tuberculosis, Including Rifampin-Resistant Strains, and Considerations for Its Use — United States, 2013
MMWR 2013; 62 (No. 41)
PDF
(275 KB)
10/2013
Recommendations for Use of an Isoniazid–Rifapentine Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis Infection
MMWR 2011; 60:1650–1653
PDF
(1.1 MB)
12/2011
Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection — United States, 2010
MMWR 2010; 59 (RR-5); 1-25
PDF
(502 KB)
6/2010
Guidelines for the Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children
MMWR
2009; 58: 1-166
PDF
(2.2 MB)
3/2009
Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents
MMWR 2009; 58: 1-198
PDF
(2.2 MB)
3/2009
Plan to Combat Extensively Drug-Resistant Tuberculosis
MMWR 2009; 58 (RR-03)
PDF
(752 KB)
2/2009
Updated Guidelines for the Use of Nucleic Acid Amplification Tests in the Diagnosis of Tuberculosis
MMWR 2009; 58 (01); 7-10
PDF
(1.2 MB)
1/2009
Report of Expert Consultations on Rapid Molecular Testing to Detect Drug-Resistant Tuberculosis in the United States   11/2008
Report of an Expert Consultation on the Uses of Nucleic Acid Amplification Tests for the Diagnosis of Tuberculosis   11/2008
Notice to Readers: Updated Guidelines on Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis PDF
(268 KB)
1/2008
Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis PDF
(229 KB)
1/2008
Prevention and Control of Tuberculosis in Correctional and Detention Facilities: Recommendations from CDC
MMWR 2006; 55 (No. RR–09, 1–44)
PDF
(589 KB)
7/2006
Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005
MMWR
2005; 54 (No. RR-17) – Reprint
Note: The errata was removed. The corrections included in the errata have been incorporated into the reprinted guidelines.
PDF
(4.2 MB)
12/2005
Health Information for International Travel   1/2005
–2006
Guidelines for Using the QuantiFERON–TB Gold Test for Detecting Mycobacterium tuberculosis Infection, United States
MMWR 2005; 54 (No. RR–15, 1–37)
PDF
(544 KB)
12/2005
Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis: Recommendations from the National Tuberculosis Controllers Association and CDC
MMWR
2005; 54 (No. RR–15, 1–37)
PDF
(544 KB)
12/2005
Controlling Tuberculosis in the United States
Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America
MMWR 2005; 54 (No. RR–12)
PDF
(1.1 MB)
11/2005
National Plan for Reliable Tuberculosis Laboratory Services Using a Systems Approach
MMWR
2005; 54 (RR–6)
PDF
(186 KB)
4/2005
Errata: Treatment of Tuberculosis
MMWR 2005; 52 (RR–11)
PDF
(499 KB)
1/2005
New CDC Program for Rapid Genotyping of Mycobacterium tuberculosis Isolates
MMWR 2005; 54 (No. 02)
PDF
(483 KB)
1/2005
Treating Opportunistic Infections Among HIV–Infected Adults and Adolescents
MMWR 2004; 53 (RR15)
PDF
(1.9 MB)
12/2004
Treating Opportunistic Infections Among HIV–Exposed and Infected Children
MMWR 2004; 53 (RR14)
PDF
(742 KB)
12/2004
Tuberculosis Associated with Blocking Agents Against Tumor Necrosis Factor – Alpha – California, 2002–2003
MMWR
2004; 53 (No. 30)
PDF
(325 KB)
8/2004
Guide to the Application of Genotyping to Tuberculosis Prevention and Control PDF
(763 KB)
6/2004
Update: Adverse Event Data and Revised American Thoracic Society/CDC Recommendations Against the Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection
MMWR 2003; 52 (No. 31)
PDF
(587 KB)
8/2003
Treatment of Tuberculosis
MMWR
2003; 52 (No. RR–11)
PDF
(1.5 MB)
6/2003
Guidelines for Environmental Infection Control in Health–Care Facilities
MMWR
2003; 52 (No. RR–10)
PDF
(1.1 mB)
6/2003
Timing of Tuberculosis Screening and Smallpox Vaccination – Recommendations for Using Smallpox Vaccine in a Pre–Event Vaccination Program
MMWR
2003; 52 (No. RR–7)
PDF
(237 KB)
4/2003
Guidelines for Preventing Opportunistic Infections Among HIV–Infected Persons — 2002
MMWR
2002; 51 (No. RR–8)
PDF
(776 KB)
6/2002
Progressing Toward Tuberculosis Elimination in Low–Incidence Areas of the United States
MMWR
2002; 51 (No. RR–5)
PDF
(329 KB)
5/2002
General Recommendations on Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP)
MMWR 2002; 51 (No. RR–2).
PDF
(6.3 MB)
2/2002
Preventing and Controlling Tuberculosis Along the U.S.–Mexico Border Work Group Report
MMWR
2001; 50 (No. RR–1)
PDF
(550 KB)
1/2001
Update: Nucleic Acid Amplification Tests for Tuberculosis
MMWR 2000; 49 (No. 26)
PDF
(136 KB)
7/2000
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection
MMWR
2000; 49 (No. RR–6)
Updates
PDF
(350 KB)
6/2000
Updated Guidelines for the Use of Rifabutin or Rifampin for the Treatment and Prevention of Tuberculosis Among HIV–Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors
MMWR
2000; 49 (No. 9)
PDF
(241 KB)
3/2000
Diagnostic Standards / Classification of TB in Adults and Children — Am J Respir Crit Care Med 2000; 161 PDF
(151 KB)
2000
Tuberculosis Elimination Revisited: Obstacles, Opportunities, and a Renewed Commitment (ACET)
MMWR
1999; 48 (No. RR–9)
PDF
(211 KB)
8/1999
Recommendations for Prevention and Control of Tuberculosis among Foreign–Born Persons
MMWR
1998; 47 (No. RR–16)
PDF
(293 KB)
9/1998
Development of new Vaccines for Tuberculosis
MMWR
1998; 47 (No. RR–13)
PDF
(171 KB)
8/1998
Nucleic Acid Amplification Tests for Tuberculosis.
MMWR 1996; 45 (No. 43)
PDF
(303 KB)
11/1996
Prevention and Control of Tuberculosis in Correctional Facilities (ACET)
MMWR
1996; 45 (No. RR–8)
PDF
(313 KB)
6/1996
The Role of BCG Vaccine in the Prevention and Control of Tuberculosis in the United States. (ACET and ACIP)
MMWR
1996; 45 (RR–4)
PDF
(266 KB)
4/1996
Essential Components of a Tuberculosis Prevention and Control Program (ACET)
MMWR
1995; 44 (No. RR–11)
PDF
(358 KB)
9/1995
Tuberculosis Control Laws – United States, 1993 (ACET)
MMWR
1993; 42 (No. RR–15)
PDF
(253 KB)
11/1993
Recommendations of the Advisory Committee on Immunization Practices (ACIP): Use of Vaccines and Immune Globulins in Persons with Altered Immunocompetence
MMWR 1993; 42 (No. RR-4)
PDF
(237 KB)
04/1993

 

Archived TB Guidelines

Title Format Date Published
Notice to Readers: Updated Guidelines for the Use of Rifamycins for the Treatment of Tuberculosis Among HIV–Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors
MMWR 2004; 53 (No. 2)
PDF
(346 KB)
1/2004
Guidelines for Using the QuantiFERON®–TB Test for Diagnosing Latent Mycobacterium tuberculosis Infection
MMWR
2002; 51 (12/18/02)
PDF
(398 KB)
1/2003
Public Health Dispatch: Update:
Fatal and Severe Liver Injuries Associated with Rifampin and Pyrazinamide Treatment for Latent Tuberculosis Infection
MMWR
2002; 51 (No. 44)
PDF
(1.7 MB)
11/2002
Diagnostic Standards and Classification of Tuberculosis in Adults and Children
Am J Respir Crit Care Med 2000; 161
PDF
168 KB)
7/1999
Prevention and Treatment of Tuberculosis among Patients Infected with Human Immunodeficiency Virus: Principles of Therapy and Revised Recommendations
MMWR 1998; 47 (No. RR–20)
PDF
(743 KB)
10/1998
Anergy Skin Testing and Preventive Therapy for HIV–Infected Persons: Revised Recommendations
MMWR
1997; 46 (No. RR–15)
PDF
(1.8 MB)
9/1997
Screening for Tuberculosis and Tuberculosis Infection in High–Risk Populations (ACET)
MMWR
1995; 44 (No. RR–11)
PDF
(358 KB)
9/1995
Guidelines for Preventing the transmission of Mycobacterium tuberculosis in Health–Care Facilities, 1994
MMWR
1994; 43 (No. RR–13)
PDF
(8.5 MB)
10/1994
Treatment of Tuberculosis and Tuberculosis Infection in Adults and Children
Am J Respir Crit Care Med 1994; 149
PDF
(300 KB)
1994
Prevention and Control of Tuberculosis in Migrant Farm Workers (ACET)
MMWR
1992; 41 (No. RR–10)
N/A 6/1992
National Action Plan to Combat Multidrug–Resistant Tuberculosis
MMWR
1992; 41 (RR–11)
N/A 6/1992
Management of Persons Exposed to Multidrug–Resistant Tuberculosis
MMWR
1992; 41 (RR–11)
N/A 6/1992
Prevention and Control of Tuberculosis in U.S. Communities with At–Risk Minority Populations (ACET)
MMWR
1992; 41 (No. RR–5)
N/A 4/1992
Prevention and Control of Tuberculosis Among Homeless Persons (ACET)
MMWR
1992; 41 (No. RR–5)
N/A 4/1992
Prevention and Control of Tuberculosis in Facilities Providing Long–Term Care to the Elderly (ACET)
MMWR
1990; 39 (RR–10)
N/A 7/1990
A Strategic Plan for the Elimination of Tuberculosis in the United States
MMWR
1989; 38 (S–3).
N/A 4/1989
 

Contact Us:
  • Centers for Disease Control and Prevention
    Division of Tuberculosis Elimination (DTBE)
    1600 Clifton Rd., NE
    MS E10
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC–INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #